Conéctate
E-mail
Contraseña
Mostrar la contraseña
Recuerde
¿Olvidó su contraseña?
Inscríbase gratis
Regístrate
Regístrate
Configuraciones
Configuraciones
Cotizaciones dinámicas 
OFFON
  1. Inicio
  2. Acciones
  3. Australia
  4. Australian Stock Exchange
  5. Anteris Technologies Ltd
  6. Noticias
  7. Otros idiomas
    AVR   AU0000088841

ANTERIS TECHNOLOGIES LTD

(AVR)
ResumenCotizacionesGráficosNoticiasAgendaEmpresaFinanzasConsensoDerivados 
ResumenTodasOtros idiomasComunicadosPubls. oficialesNoticias del sector
Noticias en otros idiomas sobre ANTERIS TECHNOLOGIES LTD
24/01Anteris Technologies Ltd Reports Successful Interim Results for the First-In-Human Tria..
10/01ANTERIS TECHNOLOGIES : Application for quotation of securities - AVR
05/01Anteris Technologies Files New Patent Application for ADAPT Technology
04/01Anteris Technologies Ltd Reports New Patent Application for ADAPT
2021ANTERIS TECHNOLOGIES : Appendix 2A
2021ANTERIS TECHNOLOGIES : Appendix 3G
2021ANTERIS TECHNOLOGIES : Application for quotation of securities - AVR
2021ANTERIS TECHNOLOGIES : Application for quotation of securities - AVR
2021ANTERIS TECHNOLOGIES : Application for quotation of securities - AVR
2021Anteris Technologies Provides DurAVR Study Update
2021ANTERIS TECHNOLOGIES : Application for quotation of securities - AVR
2021ANTERIS TECHNOLOGIES : Application for quotation of securities - AVR
2021Anteris Technologies Implants Five TAVR Patients with DurAVR Valve in Aortic Stenosis S..
2021ANTERIS TECHNOLOGIES : Notification regarding unquoted securities - AVR
2021ANTERIS TECHNOLOGIES : Application for quotation of securities - AVR
2021ANTERIS TECHNOLOGIES : Notice of Extraordinary General Meeting/Proxy Form
2021Anteris Technologies Ltd announced that it expects to receive AUD 5 million in funding ..
2021Anteris Technologies Ltd Announces Its Partnership with Iqvia Inc and the Cardiovascula..
2021Anteris Completes Key Animal Study for EFS Submission
2021ANTERIS TECHNOLOGIES : Appoints Chief Medical Officer
2021Anteris Technologies Ltd Announces the Appointment of Dr. Chris Meduri as Its Chief Med..
2021ANTERIS TECHNOLOGIES : Extends Manufacturing Deal for Bio-Scaffold Products
2021Anteris Technologies Ltd Extends Manufacturing Agreement
2021Anteris Technologies Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
2021OliveX Announces New Board Appointments And Advisory Board
2021Anteris Technologies Ltd announced that it has received AUD 9 million in funding
2021Anteris Technologies Ltd announced that it expects to receive AUD 9 million in funding
2021ANTERIS TECHNOLOGIES : Secures Patent for Sterilized Packaging System; Shares Slide 4%
2021Anteris Technologies Ltd Announced the Commonwealth of Australia Patent Office Granting..
2021ANTERIS TECHNOLOGIES : Achieves Breakthrough in Tissue Manufacturing
2021Anteris Technologies Ltd Announces Successful Completion of Proof of Concept Animal Stu..
2021ANTERIS TECHNOLOGIES : Receives Over $1 Million R&D Tax Refund
2021Anteris Technologies Ltd announced that it expects to receive AUD 2.327895 million in f..
2021ANTERIS TECHNOLOGIES : ' New Study Reveals ADAPT Technology Improves Anti-Calcification Ch..
2021Anteris Technologies Ltd reports Results from the Company's Anti-Calcification Study
2021Anteris Technologies Ltd announced that it expects to receive AUD 2.5 million in fundin..
2021Anteris Technologies Ltd Reports Earnings Results for the Full Year Ended December 31, ..
2021Anteris Technologies to Present at the BTIG Virtual MedTech, Digital Health, Life Scien..
2021Anteris Technologies Ltd announced that it expects to receive funding from Mercer Stree..
2021ANTERIS TECHNOLOGIES : Obtains Short-Term Facility
2020Anteris Technologies Announces Resignation of Yanheng Wu as A Non-Executive Director on..
2020ANTERIS TECHNOLOGIES' : DurAVR Device Wins Best Innovation at Cardiovascular Conference; S..
2020ANTERIS TECHNOLOGIES : to Present at Credit Suisse Structural Heart Forum on November 23, ..
2020Anteris Technologies to Present at Credit Suisse Structural Heart Forum on November 23,..
2020ANTERIS TECHNOLOGIES : Interim Study Finds ADAPT Treated Tissue Superior to Competitors
2020Anteris Technologies Ltd Reports Interim Results from Anti-Calcification Study
2020ANTERIS TECHNOLOGIES : Extension of Loan Facility
2020Anteris Technologies Limited Announces DurAVR Valve Patient Outcomes
2020ANTERIS TECHNOLOGIES : Cancelled Options
2020Anteris Technologies Ltd Announces Appointment of Bernard Prendergast to TAVR Medical A..
2020Anteris Technologies Ltd Reports Earnings Results for the Half Year Ended June 30, 2020
2020ADMEDUS : TAVR Key Opinion Leader Symposium
2020ADMEDUS : Expired Options
2020Anteris Technologies Ltd Provides Operations Update
2020Anteris Technologies Announces Update on Transcatheter Aortic Valve Replacement Study
2020Admedus Limited Announces Anti-Calcification Comparison Study
2020Admedus Limited has Changed its Name to Anteris Technologies Ltd
2020Admedus Limited has Changed its Ticker to AVR from AHZ
2020Admedus Limited Announces Successful Implantation of an ADAPT
2020Admedus Limited Announces US FDA Clearance for ADAPT Tissue
2020Admedus Limited Announces First Implantation of its ADAPT® Treated Single-Piece 3D Aort..
2020Admedus Limited Reports Earnings Results for the Full Year Ended December 31, 2019
2020Admedus Announces Finalisation of License with 4C Medical Technologies, Inc
2020Admedus Limited Announces Approval for First-In-Human Surgical Aortic Valve Replacement..
2019Admedus Ltd. Receives Regulatory Approval for the Sale of the Cardiocel® 3D Product Por..
2019Admedus Limited Reports Earnings Results for the Half Year Ended June 30, 2019
2019Admedus Limited Announces Terminate Distribution Agreement with arcomed ag
2019Admedus Ltd Announces Resignation of Lishan Zhang as a Non-Executive Director
2019BTC Speciality Health Pty Ltd completed the acquisition of Hospital Infusion Business f..
2019BTC Speciality Health Pty Ltd agreed to acquire Hospital Infusion Business from Admedus..
2019Anteris Technologies Ltd announced that it expects to receive AUD 1 million in funding ..
2019Admedus Ltd Receives Regulatory Approval for CardioCel 3D® and VascuCel® in Europe
2019Admedus Limited Reports Earnings Results for the Full Year Ended December 31, 2018
2019Admedus Limited Announces Interim Results from TAVR Animal Study
2019Admedus Limited Announces Change of Registered Address
1  2  3Siguiente
Próximo evento sobre ANTERIS TECHNOLOGIES LTD